Contact Information

At NeonMind Biosciences, they believe in “mind over matter”. They plan to help people change their lives by changing their minds, through treatment with psychedelics.

The first step is tackling one of the biggest health issues the world is facing right now: obesity. It’s an epidemic that is responsible for 37% of the global burden of disease. They know that being overweight puts people at risk for development of a number of chronic diseases; cardiovascular disease, diabetes, osteoarthritis, and some types of cancer. They also understand that it’s not an easy issue for people to fix on their own. Traditional weight loss methods don’t work for everyone, and often don’t address the mental health issues that are sometimes tied to obesity.

NeonMind is exploring psilocybin (a complex organic compound found in psychedelic mushrooms) as an innovative treatment approach to weight loss through a preclinical trial. They know that psilocybin is known to activate serotonin receptors, and that serotonin can curb cravings, shut off appetite, and reduce eating. They’ve hired the University of British Columbia to conduct our Preclinical Trial, exploring the potential therapeutic use of psilocybin to improve eating habits and cause weight loss.

The landscape is rapidly changing when it comes to the use of psychedelics for medical treatments. There is a major shift on the horizon and they believe in the potential for psychedelics to revolutionize the way we treat issues around mental health and obesity.